Moderna, Inc. (MRNA)
NASDAQ: MRNA · IEX Real-Time Price · USD
110.31
-1.31 (-1.17%)
At close: Apr 30, 2024, 4:00 PM
110.48
+0.17 (0.15%)
After-hours: Apr 30, 2024, 7:59 PM EDT
Moderna Revenue
In the year 2023, Moderna had annual revenue of $6.85B, a decrease of -64.45%. Revenue in the quarter ending December 31, 2023 was $2.81B, a -44.71% decrease year-over-year.
Revenue (ttm)
$6.85B
Revenue Growth
-64.45%
P/S Ratio
6.17
Revenue / Employee
$1,222,857
Employees
5,600
Market Cap
42.24B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
Dec 31, 2019 | 60.00M | -75.07M | -55.58% |
Dec 31, 2018 | 135.07M | -70.76M | -34.38% |
Dec 31, 2017 | 205.83M | 97.43M | 89.88% |
Dec 31, 2016 | 108.40M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cencora | 271.58B |
Centene | 155.52B |
Takeda Pharmaceutical | 29.40B |
GE HealthCare Technologies | 19.55B |
Becton, Dickinson and Company | 19.49B |
IQVIA Holdings | 14.98B |
Agilent Technologies | 6.74B |
Edwards Lifesciences | 6.00B |
MRNA News
- 5 days ago - Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress - Accesswire
- 6 days ago - Moderna and OpenAI Collaborate To Advance mRNA Medicine - Accesswire
- 7 days ago - Pfizer vs Moderna battle over COVID vaccine patents begins in UK - Reuters
- 8 days ago - Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National Vaccination Campaign - Accesswire
- 13 days ago - Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024 - Accesswire
- 18 days ago - Moderna Betrays Africa, Says AHF - Business Wire
- 19 days ago - Moderna halts plans to build Kenya vaccine plant as Covid shot demand plunges - CNBC
- 19 days ago - Moderna puts Kenya plant plans on hold as COVID vaccine demand slumps - Reuters